Huang Jianhao, Qiu Yanyu, Bai Xuesong, He Xiaodong
Department of General Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China.
Front Surg. 2024 Jul 23;11:1414870. doi: 10.3389/fsurg.2024.1414870. eCollection 2024.
Lymph node involvement is recognized as a prognostic factor for patients with gallbladder cancer. However, the N stage varied from different editions of the American Joint Committee on Cancer (AJCC) TNM Classification. Our objective was to investigate the impact of lymph node involvement on overall survival in elderly patients with non-metastatic gallbladder adenocarcinoma.
Patients older than 65 years with non-metastatic gallbladder adenocarcinoma were identified from the SEER data. We used Cox proportional hazard regression analysis to select the independent risk factor. A nomogram was built to identify the 1-, 3-, and 5-years' prognostic impact. Univariate and multivariate models were used to examine the correlation of overall survival (OS) with the number of metastatic nodes.
A total of 1,654 patients (706 with and 948 without nodal involvement) were included. Cox proportional hazard regression analyses found that age, gender, tumor size, lymph node involvement, and surgical options were risk factors for the prognosis and were integrated into the nomogram. After adjustment, OS was compromised for patients who receive surgery with nodal involvement [hazard ratio (HR), 2.238; < 0.01]. Furthermore, after adjustment the presence of more than two metastatic lymph nodes was associated with decreased OS (HR, 3.305; < 0.01).
Our results suggest that lymph node involvement is associated with compromised survival in elderly patients. A nomogram was developed to predict the prognosis of gallbladder cancer. A change point of more than two metastatic lymph nodes seems to carry prognostic significance, calling for closer monitoring of elderly patients with gallbladder cancer with involvement of increased number of lymph nodes.
淋巴结受累被认为是胆囊癌患者的一个预后因素。然而,美国癌症联合委员会(AJCC)TNM分期的不同版本中N分期有所不同。我们的目的是研究淋巴结受累对老年非转移性胆囊腺癌患者总生存期的影响。
从监测、流行病学与最终结果(SEER)数据中识别出年龄大于65岁的非转移性胆囊腺癌患者。我们使用Cox比例风险回归分析来选择独立危险因素。构建了一个列线图以确定1年、3年和5年的预后影响。使用单变量和多变量模型来检验总生存期(OS)与转移淋巴结数量之间的相关性。
共纳入1654例患者(706例有淋巴结受累,948例无淋巴结受累)。Cox比例风险回归分析发现年龄、性别、肿瘤大小、淋巴结受累情况和手术方式是预后的危险因素,并将其纳入列线图。调整后,有淋巴结受累的患者接受手术后OS受损[风险比(HR),2.238;P<0.01]。此外,调整后,有两个以上转移淋巴结与OS降低相关(HR,3.305;P<0.01)。
我们的结果表明,淋巴结受累与老年患者的生存受损相关。开发了一个列线图来预测胆囊癌的预后。两个以上转移淋巴结的变化点似乎具有预后意义,这就要求对淋巴结受累数量增加的老年胆囊癌患者进行更密切的监测。